PERITONEAL MALIGNANT MESOTHELIOMA

Clinical trials for PERITONEAL MALIGNANT MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new PERITONEAL MALIGNANT MESOTHELIOMA trials appear

Sign up with your email to follow new studies for PERITONEAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

New hope for rare abdominal cancer: adding immune boost to standard treatment

Disease control Recruiting now

This study is testing if adding an immunotherapy drug (atezolizumab) to standard chemotherapy works better for controlling peritoneal mesothelioma, a rare cancer in the abdomen's lining. It will involve about 66 newly diagnosed patients who will be randomly assigned to receive ei…

Matched conditions: PERITONEAL MALIGNANT MESOTHELIOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

PERITONEAL MALIGNANT MESOTHELIOMA

Get alerted when new PERITONEAL MALIGNANT MESOTHELIOMA trials appear

New hope for rare abdominal cancer: adding immune boost to standard treatment